Effect of nicotinamide riboside on airway inflammation in COPD: a randomized, placebo-controlled trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Effect of nicotinamide riboside on airway inflammation in COPD: a randomized, placebo-controlled trial ; volume:4 ; number:12 ; day:15 ; month:11 ; year:2024 ; pages:1772-1781 ; date:12.2024
Nature aging ; 4, Heft 12 (15.11.2024), 1772-1781, 12.2024
- Urheber
-
Norheim, Kristoffer L.
Ezra, Michael Ben
Heckenbach, Indra
Andreasson, Louise Munkholm
Eriksen, Lise Lotte
Dyhre-Petersen, Nanna
Damgaard, Mads Vargas
Berglind, Magnus
Pricolo, Luca
Sampson, Dayle
Dellinger, Ryan W.
Sverrild, Asger
Treebak, Jonas T.
Ditlev, Sisse Bolm
Porsbjerg, Celeste
Scheibye-Knudsen, Morten
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s43587-024-00758-1
- URN
-
urn:nbn:de:101:1-2502252118096.087120527613
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Norheim, Kristoffer L.
- Ezra, Michael Ben
- Heckenbach, Indra
- Andreasson, Louise Munkholm
- Eriksen, Lise Lotte
- Dyhre-Petersen, Nanna
- Damgaard, Mads Vargas
- Berglind, Magnus
- Pricolo, Luca
- Sampson, Dayle
- Dellinger, Ryan W.
- Sverrild, Asger
- Treebak, Jonas T.
- Ditlev, Sisse Bolm
- Porsbjerg, Celeste
- Scheibye-Knudsen, Morten
- SpringerLink (Online service)
Ähnliche Objekte (12)
Oral nicotinamide mononucleotide (NMN) to treat chronic insomnia: protocol for the multicenter, randomized, double-blinded, placebo-controlled trial
Indacaterol provides 24-hour bronchodilation in COPD: a placebo-controlled blinded comparison with tiotropium
Concomitant therapy with Cineole (Eucalyptole) reduces exacerbations in COPD: A placebo-controlled double-blind trial
Dexamethasone to prevent postextubation airway obstruction in adults: a prospective, randomized, double-blind, placebo-controlled study
Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study
The effect of vitamin D on COPD exacerbation: a double blind randomized placebo-controlled parallel clinical trial
Is nebulized saline a placebo in COPD?
Author Correction: Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study
Protocol of a randomized, double-blind, placebo-controlled, parallel-group, multicentre study of the efficacy and safety of nicotinamide in patients with Friedreich ataxia (NICOFA)
Safety and Metabolism of Long-term Administration of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, Placebo-controlled Clinical Trial of Healthy Overweight Adults
Old dilemma: asthma with irreversible airway obstruction or COPD
Correlation between sestrin2 expression and airway remodeling in COPD
Oral nicotinamide mononucleotide (NMN) to treat chronic insomnia: protocol for the multicenter, randomized, double-blinded, placebo-controlled trial
Indacaterol provides 24-hour bronchodilation in COPD: a placebo-controlled blinded comparison with tiotropium
Concomitant therapy with Cineole (Eucalyptole) reduces exacerbations in COPD: A placebo-controlled double-blind trial
Dexamethasone to prevent postextubation airway obstruction in adults: a prospective, randomized, double-blind, placebo-controlled study
Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study
The effect of vitamin D on COPD exacerbation: a double blind randomized placebo-controlled parallel clinical trial
Is nebulized saline a placebo in COPD?
Author Correction: Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study
Protocol of a randomized, double-blind, placebo-controlled, parallel-group, multicentre study of the efficacy and safety of nicotinamide in patients with Friedreich ataxia (NICOFA)
Safety and Metabolism of Long-term Administration of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, Placebo-controlled Clinical Trial of Healthy Overweight Adults
Old dilemma: asthma with irreversible airway obstruction or COPD
Correlation between sestrin2 expression and airway remodeling in COPD
Oral nicotinamide mononucleotide (NMN) to treat chronic insomnia: protocol for the multicenter, randomized, double-blinded, placebo-controlled trial
Indacaterol provides 24-hour bronchodilation in COPD: a placebo-controlled blinded comparison with tiotropium
Concomitant therapy with Cineole (Eucalyptole) reduces exacerbations in COPD: A placebo-controlled double-blind trial
Dexamethasone to prevent postextubation airway obstruction in adults: a prospective, randomized, double-blind, placebo-controlled study
Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study
The effect of vitamin D on COPD exacerbation: a double blind randomized placebo-controlled parallel clinical trial
Is nebulized saline a placebo in COPD?
Author Correction: Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study
Protocol of a randomized, double-blind, placebo-controlled, parallel-group, multicentre study of the efficacy and safety of nicotinamide in patients with Friedreich ataxia (NICOFA)
Safety and Metabolism of Long-term Administration of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, Placebo-controlled Clinical Trial of Healthy Overweight Adults
Old dilemma: asthma with irreversible airway obstruction or COPD